MRI in traumatic spinal cord injury: from clinical assessment to neuroimaging biomarkers.


Journal

The Lancet. Neurology
ISSN: 1474-4465
Titre abrégé: Lancet Neurol
Pays: England
ID NLM: 101139309

Informations de publication

Date de publication:
12 2019
Historique:
received: 03 09 2018
revised: 22 03 2019
accepted: 28 03 2019
pubmed: 14 8 2019
medline: 13 6 2020
entrez: 14 8 2019
Statut: ppublish

Résumé

Traumatic spinal cord injury occurs when an external physical impact damages the spinal cord and leads to permanent neurological dysfunction and disability, and it is associated with a high socioeconomic burden. Conventional MRI plays a crucial role in the diagnostic workup as it reveals extrinsic compression of the spinal cord and disruption of the discoligamentous complex. Additionally, it can reveal macrostructural evidence of primary intramedullary damage such as haemorrhage, oedema, post-traumatic cystic cavities, and tissue bridges. Quantitative MRI, such as magnetisation transfer, magnetic resonance relaxation mapping, and diffusion imaging, enables the tracking of secondary changes across the neuraxis at the microstructural level. Both conventional MRI and quantitative MRI metrics, obtained early after spinal cord injury, are predictive of clinical outcome. Thus, neuroimaging biomarkers could serve as surrogate endpoints for more efficient future trials targeting acute and chronic spinal cord injury. The adoption of neuroimaging biomarkers in centres for spinal cord injury might lead to personalised patient care.

Identifiants

pubmed: 31405713
pii: S1474-4422(19)30138-3
doi: 10.1016/S1474-4422(19)30138-3
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1123-1135

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Patrick Freund (P)

Spinal Cord Injury Centre Balgrist, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Department of Neurology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Department of Brain Repair and Rehabilitation, Institute of Neurology, University College London, London, UK; Wellcome Centre for Human Neuroimaging, Institute of Neurology, University College London, London, UK; Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany. Electronic address: patrick.freund@balgrist.ch.

Maryam Seif (M)

Spinal Cord Injury Centre Balgrist, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.

Nikolaus Weiskopf (N)

Wellcome Centre for Human Neuroimaging, Institute of Neurology, University College London, London, UK; Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.

Karl Friston (K)

Wellcome Centre for Human Neuroimaging, Institute of Neurology, University College London, London, UK.

Michael G Fehlings (MG)

University of Toronto Spine Program and Toronto Western Hospital, Toronto, Ontario, Canada.

Alan J Thompson (AJ)

Department of Brain Repair and Rehabilitation, Institute of Neurology, University College London, London, UK.

Armin Curt (A)

Spinal Cord Injury Centre Balgrist, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH